Dietary Intervention With the Modified Atkins Diet in Stroke Rehabilitation
Dietary Intervention in Stroke Recovery in the Acute Rehabilitation Setting With the Modified Atkins Diet.
1 other identifier
interventional
20
1 country
1
Brief Summary
This phase 1 study tests whether use of the Modified Atkins Diet (MAD) can improve motor impairment after stroke. It is based on the hypothesis that after stroke, the brain's utilization of glucose, it's primary source of energy, is disrupted. The MAD is a low-carbohydrate diet that has can switch the body's metabolism from using glucose to using products of fat metabolism, so-called ketones. Ketones may act as an alternative energy substrate for the brain. Ketones also have several neuroprotective effects after stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 stroke
Started Mar 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 13, 2013
CompletedFirst Posted
Study publicly available on registry
March 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedFebruary 24, 2016
February 1, 2016
2.2 years
March 13, 2013
February 22, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Upper Extremity Fugl Meyer Motor Score
The Upper Extremity Fugl Meyer Motor Score is used to assess impairment in upper extremity function. Individuals are asked to complete a certain sequence of movements, and quality of movements is scored.
assessed upon beginning of the study, discharge from Burke Rehabilitation Hospital (average 25 days post study enrollment) and at 3 months post discharge
Secondary Outcomes (1)
Change in Montreal Cognitive Assessment (MOCA)
assessed upon beginning of the study, discharge from Burke Rehabilitation Hospital (average 25 days post study enrollment) and at 3 months post discharge
Study Arms (2)
Modified Atkins Diet
EXPERIMENTALPatients will receive a 14 day menu consisting of the Modified Atkins diet, a low-carbohydrate, high protein, high fat diet.
Control Diet
PLACEBO COMPARATORPatients will receive a diet (e.g. regular, low cholesterol, diabetic) determined by the attending physician.
Interventions
The control diet is a diet determined by the attending physician caring for the patient and may consist of either a low sodium diet, a low sodium/ low cholesterol diet, a regular diet or a diabetic diet.
Eligibility Criteria
You may qualify if:
- Age 18-99
- First time unilateral hemispheric ischemic stroke. Not more than 12 weeks after acute stroke.
- Burke Stroke Rehabilitation Unit Inpatient.
- Preserved cognitive ability to understand commands and participate in outcome measures and to give informed consent. In patients with aphasia, cognitive ability to give consent will be determined by a physician.
- Upper extremity motor impairment with an UE Fugl Meyer score ≤ 56/66
- Independence in ADLS/ absence of major impairment prior to stroke
You may not qualify if:
- Hemorrhagic stroke
- Uncontrolled hyperlipidemia with LDL \> 250 on admission
- Uncontrolled Diabetes mellitus with BS \> 300 averaged over the first day of admission
- Nutritional risk as defined by BMI \< 18.5 or by a score of 2 or higher on the Malnutrition Universal Screening Tool (scores BMI, % of unplanned weight loss in last 3-6 months and question whether patient is acutely ill)
- Decreased renal function with eGFR \<30%
- Stage III and IV pressure ulcers
- Osteoporosis not sufficiently treated with oral Calcium and Vitamin D supplements
- CHF as defined by class III or worse
- Hypersensitivity/allergy to cholesterol lowering medications
- H/o kidney stones within last 1 year prior to stroke or medications predisposing to kidney stones such as Topamax, carboanhydrase inhibitors
- Inability to tolerate an oral diet and need for tube feeds
- Cognitively unable to follow instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Burke Rehabilitation Hospital
White Plains, New York, 10605, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carolin I Dohle, MD
Burke Rehabilitation Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurology Attending
Study Record Dates
First Submitted
March 13, 2013
First Posted
March 29, 2013
Study Start
March 1, 2012
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
February 24, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data will not be disclosed.